January 09, 2025

curATime is looking for partners!

curATime is looking for partners!

The curATime cluster is one of 14 pioneering “Clusters4Future” initiatives funded by the German Federal Ministry of Education and Research (BMBF). Its mission is to promote personalized approaches to combat atherothrombosis-related diseases and to establish the Rhine-Main-Palatinate region as an international driver of innovation.

For the planned second implementation phase, the cluster is seeking new partners from science and industry who share its passion for revolutionary research in the field of cardiovascular diseases. It welcomes companies and institutions that can complement its existing expertise in artificial intelligence and mRNA technology and wish to actively contribute to the success of the cluster.

The curATime cluster aims to develop the next generation of medical solutions and revolutionise patient care!
Contact them for more information:

Our latest News

discover more
Medizin im digitalen Zeitalter: Forum Gesundheitsstandort präsentiert Technologie-Projekte bei der DMEA 2025

Medizin im digitalen Zeitalter: Forum Gesundheitsstandort präsentiert Technologie-Projekte bei der DMEA 2025

(Stuttgart, 26.03.2025)  Daten retten Leben. Denn mit neuen Technologien und mit der Unterstützung von Künstlicher Intelligenz lassen sich riesige Mengen medizinischer Daten verlässlicher als je zuvor auswerten. So können Krankheiten frühzeitiger erkannt und behandelt werden. Dazu aber gilt es, die Daten optimal miteinander zu vernetzen, damit Ärztinnen, Ärzte, Kliniken und Pflegende ihre Patientinnen und Patienten bestmöglich […]

How chromosomes shape up for cell division

How chromosomes shape up for cell division

EMBL scientists have shown how overlapping loops of DNA stack upon each other in dividing cells to give rise to rod-shaped chromosomes Summary Among the many marvels of life is the cell’s ability to divide and thus enable organisms to grow and renew themselves. For this, the cell must duplicate its DNA – its genome […]

Resistance mechanism in chronic lymphocytic leukemia identified

Resistance mechanism in chronic lymphocytic leukemia identified

Researchers at the German Cancer Research Center (DKFZ) have succeeded in identifying a resistance mechanism that often occurs in a specific targeted therapy against chronic lymphocytic leukemia (CLL). The drug ibrutinib is effective in many cases, but therapy resistance often develops during the course of treatment. In cell culture experiments and in mice, the resistance […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp